Hand sanitizer MRSA-prevention claims unproven

Share this article:

The FDA has issued warning letters to four hand sanitizer manufacturers to cease making claims that its' products prevent methicillin-resistant Staphylococcus aureus infections.

“MRSA is a serious public health threat,” Deborah Autor, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research, said in a press release. The FDA cannot allow companies to mislead consumers by making unproven prevention claims.”

The following companies and products are in question:

  • Tec Laboratories for Staphaseptic First Aid Antiseptic/Pain Relieving Gel;
  • JD Nelson and Associates for Safe4Hours Hand Sanitizing lotion and Safe4Hours First Aid Antiseptic Skin Protectant;
  • Dr. G.H. Tichenor Antiseptic Co. for Dr. Tichenor's Antiseptic Gel;
  • Oh So Clean, Inc. for CleanWell Hand Sanitizing Wipes and CleanWell All-Natural Antibacterial Foaming Hand Soap.

The FDA said that there is not sufficient evidence to demonstrate that these products effectively prevent MRSA infections, or infections from other bacteria listed on the packaging of some products, including Escherichia coli and influenza A H1N1.

The companies will have 15 days to correct the violations cited in the letters, or face legal action including seizure and injunction.

Consumers should contact their health care provider if a skin infection treated with these products worsens or does not improve. The FDA encourages health care professionals and patients to report adverse events to MedWatch.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.
close

Next Article in Web Exclusives

More in Web Exclusives

Primary-care providers can help identify intimate-partner violence

Primary-care providers can help identify intimate-partner violence

More than half of the male survey respondents who reported violence against their spouse or partner had at least one routine health visit within the past year.

Urge all patients to get flu vaccine

Urge all patients to get flu vaccine

Flu-related complications last year caused more than 100 deaths in children and most of whom were not vaccinated.

Insulin pumps decrease mortality, cardiovascular disease risk

Insulin pumps decrease mortality, cardiovascular disease risk

Compared with multiple daily injections, patients who used continuous subcutaneous insulin infusion (CSII) had a lower likelihood of developing cardiovascular disease.